II
MRNA icon

IFM Investors’s Moderna MRNA Stock Holding History

IFM Investors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-59,798
Closed -$1.7M – 643
2025
Q1 		$1.7M Sell
59,798
-1,075
-2% -$38.1K 0.02% 524
2024
Q4 		$2.53M Sell
60,873
-3,227
-5% -$154K 0.03% 482
2024
Q3 		$4.28M Sell
64,100
-387
-0.6% -$35.5K 0.04% 389
2024
Q2 		$7.66M Sell
64,487
-109
-0.2% -$13.8K 0.08% 246
2024
Q1 		$6.88M Buy
64,596
+682
+1% +$68.7K 0.08% 271
2023
Q4 		$6.36M Sell
63,914
-1,838
-3% -$155K 0.08% 261
2023
Q3 		$6.79M Buy
65,752
+2,885
+5% +$322K 0.09% 237
2023
Q2 		$7.64M Buy
62,867
+800
+1% +$107K 0.1% 206
2023
Q1 		$9.53M Buy
62,067
+1,288
+2% +$212K 0.14% 140
2022
Q4 		$10.9M Buy
60,779
+952
+2% +$156K 0.18% 116
2022
Q3 		$7.08M Buy
59,827
+1,003
+2% +$152K 0.13% 163
2022
Q2 		$8.4M Buy
58,824
+5,093
+9% +$728K 0.15% 145
2022
Q1 		$9.26M Buy
53,731
+8,607
+19% +$1.45M 0.14% 143
2021
Q4 		$11.5M Buy
45,124
+82
+0.2% +$24K 0.21% 93
2021
Q3 		$17.3M Buy
45,042
+3,871
+9% +$1.43M 0.36% 53
2021
Q2 		$9.67M Buy
41,171
+11,493
+39% +$2.05M 0.2% 105
2021
Q1 		$3.89M Buy
29,678
+3,283
+12% +$476K 0.1% 202
2020
Q4 		$2.76M Buy
26,395
+4,256
+19% +$431K 0.09% 235
2020
Q3 		$1.57M Buy
22,139
+1,867
+9% +$130K 0.07% 282
2020
Q2 		$1.3M Buy
+20,272
New +$1.11M 0.07% 291

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IFM Investors's MRNA Position: Q2 2025 in Review

IFM Investors sold out of Moderna (MRNA) in Q2 2025, closing a stake of 59,798 shares — an estimated $1.7M sold.

IFM Investors first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $17.3M in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • IFM Investors reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • IFM Investors sold 59,798 Moderna shares in Q2 2025, an estimated $1.7M.
  • IFM Investors first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • IFM Investors's Moderna position peaked at $17.3M in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on IFM Investors's 13F filing for Q2 2025, filed 11 Jul 2025.